---
figid: PMC9657855__ijms-23-13161-g003
pmcid: PMC9657855
image_filename: ijms-23-13161-g003.jpg
figure_link: /pmc/articles/PMC9657855/figure/ijms-23-13161-f003/
number: Figure 3
figure_title: ''
caption: 'Effect of storax on cardiac function in ISO-induced AMI rats. (A) Representative
  images of M-mode echocardiography and mitral pulse Doppler. (B) Ejection fraction
  (EF). (C) Shortening fraction (FS). (D) Left ventricular end-systolic inner diameters
  (LVIDs). (E) Left ventricular end-systolic volume (LVESV). (F) MV E/A. Results are
  presented as mean ± SD (n = 6). One-way ANOVA followed by Bonferroni’s post hoc
  test: * p < 0.05, ** p < 0.01 vs. model group; # p < 0.05, ## p < 0.01 vs. vehicle
  group.'
article_title: Storax Attenuates Cardiac Fibrosis following Acute Myocardial Infarction
  in Rats via Suppression of AT1R–Ankrd1–P53 Signaling Pathway.
citation: Zhuo Xu, et al. Int J Mol Sci. 2022 Nov;23(21):13161.
year: '2022'

doi: 10.3390/ijms232113161
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- storax
- myocardial infarction
- cardiac fibrosis
- cardiac dysfunction
- AT1R–Ankrd1–P53

---
